TP53 encodes the p53 protein, a critical tumor suppressor that acts as a transcription factor to protect cells from damage. When activated by cellular stress such as DNA damage, p53 triggers responses including DNA repair, cell cycle arrest, and programmed cell death (apoptosis) to prevent the propagation of damaged cells. TP53 is the most frequently mutated gene in human cancers, and loss of its function contributes to tumor development, invasion, drug resistance, and genomic instability. Inherited mutations in TP53 cause Li-Fraumeni syndrome, a rare hereditary condition that greatly increases the risk of developing multiple types of cancer at a young age.

TP53 is a critical tumor suppressor whose inherited mutations cause Li-Fraumeni syndrome, making accurate variant classification essential for cancer-risk management. This deep intronic variant (c.919+17A>G) is classified as a VUS: it is extremely rare in the general population, but no functional or splicing evidence currently exists to determine whether it affects p53 function or cancer risk.